THETFORD MINES, QC, Dec. 12, 2024 /CNW/ - KDA Group Inc. (TSXV: KDA) ("KDA" or the "Corporation"), a leader in innovative technological solutions for healthcare professionals, is pleased to announce that its subsidiary, Groupe Technologique KDA ("Tech KDA"), in partnership with Pharmacie Horizon Santé and Dr. Éric Poirier, surgical oncologist practicing at the Clinique des Maladies du Sein at the Centre Hospitalier Universitaire de Québec (CHU de Québec-Université Laval), has signed a letter of intent, dated December 11, 2024, to integrate the innovative Medherize platform. This project aims to address the complex challenges associated with managing outpatient oncology treatments for breast cancer patients.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
